* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's PEG Ratio or its related term are showing as below:
NSA:GLAXOSMITH'
s PEG Ratio Range Over the Past 10 Years
Min: 0.71 Med: 1.14 Max: 12.59
Current: 11.86
During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest PEG Ratio was 12.59. The lowest was 0.71. And the median was 1.14.
NSA:GLAXOSMITH's PEG Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.655
vs NSA:GLAXOSMITH: 11.86
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
GlaxoSmithKline Consumer Nigeria PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GlaxoSmithKline Consumer Nigeria's PEG Ratio
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Consumer Nigeria's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's PEG Ratio distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's PEG Ratio falls into.
GlaxoSmithKline Consumer Nigeria PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
GlaxoSmithKline Consumer Nigeria PEG Ratio Related Terms
Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSA:GLAXOSMITH has been successfully added to your 